Clinical Trial Update: Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the Phase 1/2 study of the duvelisib and venetoclax combination in relapsed or refractory Chronic Lymphocytic Leukemia, Small lymphocyt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Richter Syndrome
• Small Lymphocytic Lymphoma

Drugs mentioned

• COPIKTRA (duvelisib)
• Venclexta (venetoclax)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Chronic Lymphocytic Leukemia, Richter Syndrome | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-03-23